Pictet Asset Management (UK)’s Charles River Laboratories CRL Stock Holding History

Pictet Asset Management (UK)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$7.5M	Buy	20,265 +16,565	+448%	+$5.53M	0.01%	760
2021 Q1	$1.07M	Sell	3,700 -500	-12%	-$139K	﹤0.01%	1048
2020 Q4	$1.05M	Buy	4,200 +100	+2%	+$23.8K	﹤0.01%	1015
2020 Q3	$928K	Buy	4,100 +2,300	+128%	+$477K	﹤0.01%	973
2020 Q2	$314K	Buy	+1,800	New	+$287K	﹤0.01%	1007

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pictet Asset Management (UK)'s CRL Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Charles River Laboratories (CRL) stake by 448% in Q2 2021, buying an estimated $5.53M and bringing the position to 20,265 shares worth $7.5M. The position accounts for 0.01% of the portfolio, ranked #760.

Pictet Asset Management (UK) first reported a position in CRL in Q2 2020 and has held it in 5 quarters since. 638 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

Pictet Asset Management (UK) held 20,265 shares of Charles River Laboratories worth $7.5M as of Q2 2021.
Pictet Asset Management (UK) bought 16,565 Charles River Laboratories shares in Q2 2021, an estimated $5.53M.
Charles River Laboratories made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #760 holding.
Pictet Asset Management (UK) first reported a position in Charles River Laboratories in Q2 2020 and has held it in 5 quarters since.
638 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.